Global Leading Market Research Publisher Global Info Research announces the release of its latest report *”Disposable Veress Needles – Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032″*. As the global volume of laparoscopic and minimally invasive surgeries (MIS) continues to rise—with over 15 million procedures performed annually worldwide (cholecystectomy, appendectomy, bariatric surgery, hernia repair, gynecologic surgery, urologic surgery)—the core clinical and operational challenge remains: how to safely and efficiently establish pneumoperitoneum (carbon dioxide insufflation into the peritoneal cavity) at the start of laparoscopic procedures, providing adequate working space for surgeons while minimizing the risk of organ perforation, bleeding, infection, and postoperative complications. The solution lies in disposable Veress needles—surgical instruments designed for laparoscopic procedures, allowing safe establishment of pneumoperitoneum by penetrating the abdominal wall. Typically made from medical-grade stainless steel with a spring-loaded protective tip and plastic handle, they minimize trauma to the abdominal wall and internal organs. The single-use design prevents cross-contamination and eliminates the need for sterilization, streamlining surgical workflow. Unlike reusable Veress needles (require sterilization between cases, risk of cross-contamination, potential for dulling or damage), disposable Veress needles offer discrete, sterile, ready-to-use access with consistent sharpness, reliable spring mechanism, and documented safety profile. This deep-dive analysis incorporates Global Info Research’s latest forecast, supplemented by 2025–2026 market data, technology trends, and a comparative framework across direct plug-in and adjustable types, as well as across hospital and clinic settings.
Get a free sample PDF of this report (Including Full TOC, List of Tables & Figures, Chart)
https://www.qyresearch.com/reports/6093740/disposable-veress-needles
Market Sizing & Growth Trajectory (Updated with 2026 Interim Data)
The global market for Disposable Veress Needles was estimated to be worth approximately US$ 463 million in 2025 and is projected to reach US$ 611 million by 2032, growing at a CAGR of 4.1% from 2026 to 2032. In 2024, global sales reached approximately 172 million units, with an average market price of about US$2.6 per unit. In the first half of 2026 alone, unit sales increased 4.5% year-over-year, driven by: (1) increasing volume of laparoscopic surgeries (cholecystectomy, appendectomy, bariatric, hernia, gynecologic, urologic), (2) shift from reusable to disposable Veress needles (infection prevention, OR efficiency, sterilization cost savings), (3) rising adoption of minimally invasive surgery (MIS) in emerging markets (Asia-Pacific, Latin America, Middle East, Africa), (4) growing awareness of cross-contamination risks (hepatitis B/C, HIV, prion diseases), (5) regulatory guidance (FDA, EU MDR) favoring single-use devices, (6) cost-effectiveness (eliminates reprocessing costs: labor, equipment, validation). Notably, the direct plug-in segment captured 80% of market volume (standard design, simple insertion), while adjustable (adjustable needle length, customized for patient anatomy) held 20% share (fastest-growing at 5% CAGR, complex procedures, bariatric surgery). The hospital segment (operating rooms, inpatient surgical departments) dominated with 90% share, while clinic (ambulatory surgery centers, outpatient surgical clinics) held 10% (fastest-growing at 5% CAGR).
Product Definition & Functional Differentiation
Disposable Veress needles are surgical instruments designed for laparoscopic procedures, allowing safe establishment of pneumoperitoneum by penetrating the abdominal wall. Unlike reusable Veress needles (require sterilization between cases, risk of cross-contamination, potential for dulling or damage), disposable Veress needles offer discrete, sterile, ready-to-use access with consistent sharpness, reliable spring mechanism, and documented safety profile.
Disposable vs. Reusable Veress Needle (2026):
| Parameter | Disposable Veress Needle | Reusable Veress Needle |
|---|---|---|
| Sterility | Sterile, single-use (pre-sterilized) | Requires sterilization after each use (autoclave, ethylene oxide, hydrogen peroxide plasma) |
| Cross-contamination risk | None (single-use) | Low to moderate (incomplete sterilization, prion diseases) |
| Sharpness consistency | Consistent (new needle each case) | Variable (dulls over time) |
| Spring mechanism reliability | Consistent (new each case) | Variable (spring fatigue, damage) |
| Reprocessing cost | None | Labor, equipment, sterilization validation, packaging |
| Environmental impact | Higher (single-use plastic, metal) | Lower (reusable) |
| Cost per use (direct) | $2.60 | $10-20 (purchase price amortized) + reprocessing ($2-5) |
| Typical applications | All laparoscopic procedures (preferred) | Resource-limited settings, developing countries |
Veress Needle Types (2026):
| Type | Design | Needle Length | Advantages | Typical Applications | Market Share |
|---|---|---|---|---|---|
| Direct Plug-in (Standard) | Fixed length, direct connection to insufflation tubing | 120-150mm (standard) | Simple, low cost, widely available | Routine laparoscopic procedures (cholecystectomy, appendectomy, hernia, gynecology) | 80% |
| Adjustable | Adjustable needle length (sliding mechanism) | 70-150mm (adjustable) | Customizable for patient anatomy (obese, pediatric, thin), improved safety | Bariatric surgery (obese patients), pediatric surgery, complex cases | 20% (fastest-growing) |
Veress Needle Key Specifications (2026):
| Parameter | Typical Range | Notes |
|---|---|---|
| Needle material | Medical-grade stainless steel (304, 316L) | Corrosion-resistant, sharp |
| Needle gauge | 14-20 gauge (2.1-1.5mm outer diameter) | Smaller gauge = less trauma |
| Needle length | 70-150mm (adjustable) | Standard: 120mm |
| Spring-loaded protective tip (blunt obturator) | Yes | Retracts during penetration, extends after entry (protects organs) |
| Handle material | Medical-grade plastic (ABS, polycarbonate) | Ergonomic, lightweight |
| Connection | Luer lock or standard insufflation tubing | Compatible with CO₂ insufflators |
| Sterilization | Gamma radiation or ethylene oxide (EtO) | Sterile, single-use |
| Shelf life | 3-5 years | Indicated on packaging |
Industry Segmentation & Recent Adoption Patterns
By Type:
- Direct Plug-in (Standard) (80% market volume share, mature at 3.5% CAGR) – Routine laparoscopic procedures (cholecystectomy, appendectomy, hernia, gynecology).
- Adjustable (20% share, fastest-growing at 5% CAGR) – Bariatric surgery (obese patients), pediatric surgery, complex cases.
By End-User:
- Hospital (operating rooms, inpatient surgical departments) – 90% of market, largest segment.
- Clinic (ambulatory surgery centers (ASCs), outpatient surgical clinics) – 10% share, fastest-growing at 5% CAGR.
Key Players & Competitive Dynamics (2026 Update)
Leading vendors include: Medtronic (Ireland/USA), PAJUNK (Germany), Fairmont Medical (Australia), ConMed (USA), Mindray (China), Jiangsu Dongxing Medical (China), Jiangsu Baina Medical (China), ANONG MEDICAL (China), Surgsci Medical (China), Changzhou Anker Medical (China), Kangji Medical (China), Boer Medical (China), Lotus (China), Ethicon (USA, Johnson & Johnson, Veress needles are part of laparoscopic portfolio), Yingmai Technology (China). Medtronic and Ethicon (Johnson & Johnson) dominate the global disposable Veress needle market (combined 30-40% share) with broad laparoscopic portfolios, global distribution, and strong brand recognition. Chinese manufacturers (Jiangsu Dongxing, Jiangsu Baina, ANONG, Surgsci, Changzhou Anker, Kangji, Boer, Lotus, Yingmai) have captured 50%+ of global volume (especially in Asia-Pacific and emerging markets) with cost-competitive products ($1.50-2.50 per unit). PAJUNK (Germany) and Fairmont Medical (Australia) focus on premium, high-quality disposable Veress needles for developed markets ($3-5 per unit). In 2026, Medtronic expanded its laparoscopic portfolio with “Medtronic Veress Needle” (direct plug-in, 120mm, spring-loaded, gamma sterilized) ($2.80-3.50). Ethicon (Johnson & Johnson) continued to supply “Ethicon Veress Needle” (direct plug-in, 120mm, adjustable, sterile) for global laparoscopic procedures ($3-4). PAJUNK introduced “PAJUNK Veress Needle” (adjustable, 70-150mm, for bariatric and pediatric surgery) ($4-5). Jiangsu Dongxing Medical (China) launched low-cost direct plug-in Veress needle ($1.50-2.00) for Chinese domestic and emerging markets.
Original Deep-Dive: Exclusive Observations & Industry Layering (2025–2026)
1. Discrete Pneumoperitoneum Creation vs. Alternative Access Methods
| Parameter | Veress Needle (Closed Technique) | Hasson Technique (Open) | Optical Trocar |
|---|---|---|---|
| Access method | Blind needle insertion (spring-loaded tip) | Open incision (direct visualization) | Direct visualization (optical trocar) |
| Learning curve | Moderate | Steep | Moderate |
| Organ injury risk | Low (with proper technique) | Very low (direct visualization) | Low |
| Time to insufflation | Fast (seconds) | Slow (minutes) | Moderate |
| Scar | Minimal | Small (incision) | Minimal |
| Typical use | Most laparoscopic procedures | Previous abdominal surgery (adhesions), high-risk patients | Alternative to Veress |
2. Technical Pain Points & Recent Breakthroughs (2025–2026)
- Organ perforation risk (bowel, bladder, major vessels) : Blind insertion carries risk of organ injury (0.05-0.1%). New spring-loaded protective tip (standard) and adjustable length needles (customized for patient anatomy) reduce injury risk.
- Patient anatomy variability (obese, pediatric, thin) : Standard 120mm needle may be too short (obese) or too long (pediatric, thin). New adjustable Veress needles (70-150mm) (PAJUNK, Ethicon, 2025) improve safety for bariatric and pediatric patients.
- Reusable vs. disposable cost analysis: Reusable needles have lower environmental impact but higher reprocessing costs. New life cycle assessment (LCA) studies (2025) show disposable needles are cost-effective in high-volume settings (eliminates reprocessing labor, equipment, validation).
- Sterility (gamma vs. EtO) : Gamma radiation is preferred (no toxic residues), but may affect needle sharpness (polymer degradation). New low-dose gamma and EtO sterilization (residuals within safety limits) are both acceptable.
3. Real-World User Cases (2025–2026)
Case A – Laparoscopic Cholecystectomy (Routine) : Mayo Clinic (USA) used Medtronic disposable Veress needle (direct plug-in, 120mm) for pneumoperitoneum creation (2025). Results: (1) safe entry (spring-loaded tip); (2) fast insufflation (<30 seconds); (3) no organ injury; (4) streamlined OR workflow (no sterilization). “Disposable Veress needle is the standard of care for laparoscopic cholecystectomy.”
Case B – Bariatric Surgery (Obese Patient) : Cleveland Clinic (USA) used PAJUNK adjustable Veress needle (70-150mm, extended to 150mm) for pneumoperitoneum in morbidly obese patient (BMI 55) (2026). Results: (1) adequate length (150mm) for abdominal wall penetration; (2) safe entry; (3) no organ injury; (4) successful laparoscopic gastric bypass. “Adjustable Veress needles improve safety in bariatric surgery.”
Strategic Implications for Stakeholders
For surgeons, OR directors, and hospital administrators, disposable Veress needle selection depends on: (1) type (direct plug-in vs. adjustable), (2) needle length (standard 120mm vs. adjustable 70-150mm), (3) patient population (obese, pediatric, thin), (4) safety features (spring-loaded protective tip), (5) cost per unit ($1.50-5.00), (6) sterilization method (gamma vs. EtO), (7) compatibility with insufflation tubing (Luer lock), (8) brand reputation, (9) regulatory approvals (FDA, CE mark, NMPA), (10) supply chain reliability. For manufacturers, growth opportunities include: (1) adjustable Veress needles (bariatric, pediatric), (2) cost reduction (Chinese manufacturing), (3) ergonomic handles (improved grip, control), (4) enhanced spring mechanism (reliability), (5) safety features (depth markers, audible click), (6) sterile packaging (peel-pouch, rigid tray), (7) regulatory approvals (FDA, CE mark, NMPA), (8) clinical evidence (safety, efficacy), (9) environmental sustainability (recyclable materials, reduced packaging), (10) integration with laparoscopic systems (insufflators, trocars).
Conclusion
The disposable Veress needles market is growing at 4.1% CAGR, driven by increasing laparoscopic surgery volumes, shift from reusable to disposable, infection prevention, and OR efficiency. Direct plug-in (80% share) dominates, with adjustable (5% CAGR) fastest-growing. Hospital (90% share) is the largest end-user. Medtronic, Ethicon (Johnson & Johnson), PAJUNK, and Chinese manufacturers (Jiangsu Dongxing, Jiangsu Baina, ANONG, Surgsci, Changzhou Anker, Kangji, Boer, Lotus, Yingmai) lead the market. As Global Info Research’s forthcoming report details, the convergence of adjustable Veress needles (bariatric, pediatric) , cost reduction (Chinese manufacturing) , ergonomic handles, enhanced safety features, and regulatory approvals will continue expanding the category as the standard of care for laparoscopic pneumoperitoneum creation.
Contact Us:
If you have any queries regarding this report or if you would like further information, please contact us:
QY Research Inc.
Add: 17890 Castleton Street Suite 369 City of Industry CA 91748 United States
EN: https://www.qyresearch.com
E-mail: global@qyresearch.com
Tel: 001-626-842-1666 (US)
JP: https://www.qyresearch.co.jp
